Latest Migraine Stories

Hard-to-treat chronic pain, a condition that inflicts at least 116 million adult Americans a year, can cost the nation anywhere between $560 billion to $635 billion each year, according to a report from the Institute of Medicine (IOM).Addressing the highly common condition that is preventable and could be better managed requires a comprehensive strategy encompassing lost productivity and healthcare expenses, the report suggests.Chronic pain is described as pain that lasts for more than...

Familial hemiplegic migraine is a rare and severe subtype of migraine with aura, an unusual sensory experience preceding the migraine attack. Researchers from the San Raffaele Scientific Institute in Milan, and CNR Institute of Neuroscience in Pisa, Italy, have developed a mouse model of Familial Hemiplegic Migraine type 2 (FHM2) and used it to investigate the migraine's cause. The study will be published on June 23rd in the open-access journal PLoS Genetics.The researchers developed a...

MOUNTAIN VIEW, Calif., June 23, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that LEVADEX® orally inhaled migraine drug will be featured in four poster presentations, including one late-breaker presentation, at the 15th Congress of the International Headache Society (IHC) in Berlin, Germany on June 23-26, 2011. LEVADEX is an investigational drug for migraine and the Company has submitted a New Drug Application to the U.S. Food and Drug Administration for...

LOS ANGELES, June 14, 2011 /PRNewswire/ -- The makers of MigreLief, the world's most successful patented natural migraine prevention therapy, can now be seen on the popular nationally broadcast Lifetime series, "The Balancing Act." On June 20th and again on July 25th, (7:00 a.m. et/pt) this informative and entertaining show that provides a daily source of tips, knowledge and latest health news for women, will feature the first name in migraine relief, MigreLief. Being interviewed on...

REHOVOT, Israel, June 14, 2011 /PRNewswire/ -- D-Pharm Ltd., (TASE: DPRM) announced today publication, on-line, in the International Journal of Stroke the protocol for its ongoing, Phase III, Membrane Activated Chelator Stroke Intervention (MACSI) study. In this study, DP-b99 is being tested for safety and for the ability to improve outcome in moderately severe acute ischemic stroke patients. The article is available on-line at the following link...

Migraine is a neurovascular disease that affects about 15% of the western population. Compounds in foods and beverages (chocolate, wine, citrus, etc) considered as migraine triggers include tyramine, phenylethylamine and possibly histamine and phenolic compounds. Avoiding those triggers may significantly reduce the frequency of migraines in some patients.However, only a small percentage of patients in one study became headache-free simply by excluding those foods, epidemiological studies are...

According to a new study, scientists have uncovered a trio of genes tied to migraine headaches, including one in which the link is exclusive to women. Migraines are acutely debilitating headaches that up to 20 percent of the population suffer from. Scientists say the condition is a brain disorder in which neurons, or brain cells, respond abnormally to stimuli. Markus Shuerks of Brigham and Women's Hospital in Boston coordinated genomes in 23,230 women, 122 of whom suffered from migraines. The...

Topiramate is a medication that's been used for the treatment of the seizures associated with epilepsy, and in recent years it has also been used to treat the symptoms of migraine headaches. The Consumer Justice Foundation hereby announces that it has provided new information regarding the potential effects of Topiramate on unborn children of mothers who have used Topiramate for migraine headaches and who were unaware of the potential Topiramate side effects. This information can be...

CHICAGO, June 7, 2011 /PRNewswire/ -- The National Headache Foundation (NHF) announced today that it is partnering with CBS Los Angeles reporter Serene Branson to launch "More Than Just a Headache," a new education campaign to raise awareness of the prevalence and impact of migraines. The campaign helps to kick off June as National Migraine Awareness Month (NMAM) and educate the public on the personal and societal costs of migraines, while also providing resources for the 30 million...

Migraine specialists attending the American Headache Society (AHS) science meeting here this weekend say they believe that more government money for migraine research holds the most promise for winning the battle against the disease.When asked to rank four areas of research need, 40 % say an increase in public funds is more important even than understanding basic aspects of the disease -- more than early intervention in a migraine attack (28%), migraine genetics (25%), or the role of the...